Regulatory delays could hinder Mind Medicine's patient access and market entry. Read why we are initiating coverage on MNMD ...

Walgreens to Pay $300 Million in US Opioid Settlement (Reuters ... illegal and filled them anyway, violating the Controlled Substances Act. The government also alleged it violated the False ...

The settlement — announced by the U.S. Department of Justice (DOJ) on Monday — addresses claims that Walgreens and its various subsidiaries violated the Controlled Substances Act and the False ...

Per the terms of the settlement, Walgreens will pay the federal government $300 million to resolve allegations that the company violated both the Controlled Substances Act and the False Claims Act ...

Walgreens then sought payment for many of those invalid prescriptions by Medicare and other federal healthcare programs in violation of the False Claims Act. The complaint alleged that Walgreens ...

“This landmark civil settlement is the largest Controlled Substances Act resolution in our district’s history and once again confirms the high priority our office has placed upon confronting ...